Axonics, Inc. (AXNX)
NASDAQ: AXNX · IEX Real-Time Price · USD
67.45
+0.15 (0.22%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Axonics Market Cap
Axonics has a market cap or net worth of $3.44 billion as of July 2, 2024. Its market cap has increased by 37.65% in one year.
Market Cap
3.44B
Enterprise Value
3.12B
1-Year Change
37.65%
Ranking
Category
Stock Price
$67.45
Market Cap Chart
Since October 31, 2018, Axonics's market cap has increased from $379.10M to $3.44B, an increase of 807.73%. That is a compound annual growth rate of 47.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 3.43B | 8.91% |
| Dec 29, 2023 | 3.15B | 1.80% |
| Dec 30, 2022 | 3.10B | 19.45% |
| Dec 31, 2021 | 2.59B | 30.46% |
| Dec 31, 2020 | 1.99B | 150.73% |
| Dec 31, 2019 | 792.60M | 88.67% |
| Dec 31, 2018 | 420.10M | 10.82% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Waystar Holding | 3.58B |
| Perrigo Company | 3.58B |
| Dyne Therapeutics | 3.47B |
| Guardant Health | 3.46B |
| Alvotech | 3.46B |
| Corcept Therapeutics | 3.40B |
| Prestige Consumer Healthcare | 3.37B |
| iRhythm Technologies | 3.31B |